Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SAM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114075557B reveals enzymatic synthesis for high-purity Larotrectinib intermediate. Achieve cost reduction and scalable supply chain reliability.
Patent CN118726300A reveals a novel transaminase mutant for producing agrochemical intermediates with high optical purity and reduced manufacturing costs.
Patent CN1775791A details a novel route for 2-deoxy-D-glucose from glucosamine. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel aminotransferase patent enables high-purity sitagliptin intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN120718880A reveals high-efficiency biocatalysis for chiral amines. Achieve superior purity and reduced manufacturing costs with scalable enzyme technology.
Patent CN104178540A details a novel E. coli method for ademetionine. Offers high purity and yield for pharmaceutical intermediates manufacturing supply chains.
Patent CN106754806B discloses a high-efficiency transaminase for synthesizing (R)-3-aminobutanol, offering superior substrate tolerance and eliminating organic cosolvents for cost-effective manufacturing.
Patent CN106111189B reveals a novel chiral pyridoxamine catalyst enabling mild synthesis of alpha-amino acids with high ee values and scalable manufacturing potential.
Patent CN113789310B reveals high-yield transaminase route for moxifloxacin intermediates, eliminating DMSO for cost-effective and scalable API manufacturing.
Novel bisamide compounds with pyridinium salts for antibacterial crop protection. Efficient synthesis route offers significant cost advantages.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel recombinant (R)-ω-transaminase mutant enables high-yield sitagliptin production with superior stereoselectivity and enzyme activity for pharmaceutical supply chains.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111235084A reveals a cost-effective enzymatic route for S-adenosylmethionine using recombinant E. coli, offering significant supply chain advantages.
Patent CN109609477B details a novel alpha-transaminase mutant enabling 100% conversion in L-glufosinate-ammonium synthesis, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN115975969A discloses high-efficiency transaminase mutants for Sitagliptin synthesis, offering superior conversion rates and stability for cost reduction in API manufacturing.
Patent CN116004562A reveals a quadruple transaminase mutant boosting D-4,4'-biphenylalanine production efficiency by 30-fold, offering a scalable, high-purity solution for LCZ696 intermediates.
Novel synthetic method for Lacosamide intermediate ensuring 99.95% purity. Cost-effective and scalable solution for pharmaceutical manufacturing supply chains.
Patent CN104131048A reveals high-yield biological synthesis for chiral intermediates. Achieve superior purity and cost efficiency in pharmaceutical manufacturing supply chains.
Patent CN113881720B reveals enzymatic synthesis for high-purity intermediates. Achieve cost reduction and supply chain reliability with scalable biocatalysis.